Kezar Life Sciences
(NASDAQ) KZR
Kezar Life Sciences Financials at a Glance
Market Cap
$54.03M
Revenue (TTM)
$0.00
Net Income (TTM)
$56.03M
EPS (TTM)
$-7.66
P/E Ratio
-0.96
Dividend
$0.00
Beta (Volatility)
0.91 (Low)
Dividend
$0.00
Beta (Volatility)
0.91 (Low)
Price
$7.33
Volume
2,894
Open
$7.39
Price
$7.33
Volume
2,894
Open
$7.39
Previous Close
$7.33
Daily Range
$7.33 - $7.39
52-Week Range
$3.53 - $7.55
Dividend
$0.00
Beta (Volatility)
0.91 (Low)
Price
$7.33
Volume
2,894
Open
$7.39
Previous Close
$7.33
Daily Range
$7.33 - $7.39
52-Week Range
$3.53 - $7.55
KZR News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Kezar Life Sciences
Industry
Biotechnology
Sector
Health CareEmployees
9
CEO
Christopher J. Kirk, PhD
Website
www.kezarlifesciences.comHeadquarters
South San Francisco, CA 94080, US
KZR Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-60%
Return on Capital
-75%
Return on Assets
-73%
Earnings Yield
-1.04%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$54.03M
Shares Outstanding
7.37M
Volume
2.89K
Short Interest
0.00%
Avg. Volume
70.87K
Financials (TTM)
Gross Profit
$897.00K
Operating Income
$52.27M
EBITDA
$51.37M
Operating Cash Flow
$51.78M
Capital Expenditure
$8.00K
Free Cash Flow
$51.78M
Cash & ST Invst.
$71.88M
Total Debt
$2.33M
Kezar Life Sciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$176.00K
N/A
Gross Margin
0.00%
N/A
Market Cap
$54.03M
N/A
Market Cap/Employee
$982.42K
N/A
Employees
55
N/A
Net Income
$14.55M
+28.1%
EBITDA
$8.15M
+58.3%
Quarterly Fundamentals
Net Cash
$69.55M
-40.1%
Accounts Receivable
$1.93M
+354.0%
Inventory
$0.00
-100.0%
Long Term Debt
$0.00
-100.0%
Short Term Debt
$2.33M
-73.4%
Return on Assets
-73.11%
N/A
Return on Invested Capital
-74.59%
N/A
Free Cash Flow
$11.96M
+28.9%
Operating Cash Flow
$11.96M
+28.9%